According to a pan-cancer analysis based on the GEPIA, cPLA2γ/PLA2G4C expression is downregulated in nine types of tumors but not in GBM or lower grade gliomas, whereas it is upregulated in seven types of tumors [9]. The gene discussed is PLA2G4C; the disease is cancer.